According to Suven Life Sciences latest financial reports the company has an operating margin of -9.73%, an decrease of -8.55% to 2022. At the end of 2022 company had an operating margin of -10.64%.
Year | Operating Margin | Change |
---|---|---|
2023 | -9.73% | -8.55% |
2022 | -10.64% | 72.53% |
2021 | -6.17% | -25.49% |
2020 | -8.28% | - |